Last update 04 Apr 2026

YLSH003

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
YLSH003
Target
tissue factor
Action
inhibitors
Mechanism
tissue factor inhibitors(Tissue factor inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Chengdu Easton Biopharmaceuticals Co., Ltd.Chengdu Easton Biopharmaceuticals Co., Ltd.
Active Organization
Chengdu Easton Biopharmaceuticals Co., Ltd.Chengdu Easton Biopharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with YLSH003
CTR20254028
/ RecruitingPhase 1/2
评估YLSH003在晚期实体瘤患者中的安全性、耐受性、药代动力学和有效性的I/II期临床研究
[Translation] A Phase I/II clinical study evaluating the safety, tolerability, pharmacokinetics, and efficacy of YLSH003 in patients with advanced solid tumors
100 Clinical Results associated with YLSH003
Login to view more data
100 Translational Medicine associated with YLSH003
Login to view more data
100 Patents (Medical) associated with YLSH003
Login to view more data
100 Deals associated with YLSH003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
China
Chengdu Easton Biopharmaceuticals Co., Ltd.Chengdu Easton Biopharmaceuticals Co., Ltd.
23 Oct 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free